Following publication of the original article [1] the authors identified that the collaborators of the TOCIVID-19 investigators, Italy were only available in the supplementary file. The original article has been updated so that the collaborators are correctly acknowledged. For clarity, all collaborators are listed in this correction article.

Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) / Perrone, F., Piccirillo, M.C., Ascierto, P.A., Salvarani, C., Parrella, R., Marata, A.M., Popoli, P., Ferraris, L., Marrocco-Trischitta, M.M., Ripamonti, D., Binda, F., Bonfanti, P., Squillace, N., Castelli, F., Muiesan, M.L., Lichtner, M., Calzetti, C., Salerno, N.D., Atripaldi, L., Cascella, M., et al.. - In: JOURNAL OF TRANSLATIONAL MEDICINE. - ISSN 1479-5876. - 19:1(2021). [10.1186/s12967-021-03094-9]

Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

Lichtner M.;Carraro A.;Del Giudice E.;Lubrano R.;Gallo A.;Riggio O.;Cardinale V.;Ridola L.;Bragazzi M. C.;Gioia S.;Leonetti F.;Russo G.;Badagliacca R.;
2021

Abstract

Following publication of the original article [1] the authors identified that the collaborators of the TOCIVID-19 investigators, Italy were only available in the supplementary file. The original article has been updated so that the collaborators are correctly acknowledged. For clarity, all collaborators are listed in this correction article.
2021
tocilizumab; covid 19; pneumonia
01 Pubblicazione su rivista::01a Articolo in rivista
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) / Perrone, F., Piccirillo, M.C., Ascierto, P.A., Salvarani, C., Parrella, R., Marata, A.M., Popoli, P., Ferraris, L., Marrocco-Trischitta, M.M., Ripamonti, D., Binda, F., Bonfanti, P., Squillace, N., Castelli, F., Muiesan, M.L., Lichtner, M., Calzetti, C., Salerno, N.D., Atripaldi, L., Cascella, M., et al.. - In: JOURNAL OF TRANSLATIONAL MEDICINE. - ISSN 1479-5876. - 19:1(2021). [10.1186/s12967-021-03094-9]
File allegati a questo prodotto
File Dimensione Formato  
Perrone_Correction to: Tocilizumab_2021.pdf

accesso aperto

Note: https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-03094-9
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 887.46 kB
Formato Adobe PDF
887.46 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1595304
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact